Brash Alan R, Yu Zheyong, Boeglin William E, Schneider Claus
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
FEBS J. 2007 Jul;274(14):3494-3502. doi: 10.1111/j.1742-4658.2007.05909.x. Epub 2007 Jul 2.
The recent convergence of genetic and biochemical evidence on the activities of lipoxygenase (LOX) enzymes has implicated the production of hepoxilin derivatives (fatty acid epoxyalcohols) in the pathways leading to formation of the water-impermeable barrier of the outer epidermis. The enzymes 12R-LOX and eLOX3 are mutated in a rare form of congenital ichthyosis, and, in vitro, the two enzymes function together to convert arachidonic acid to a specific hepoxilin. Taken together, these lines of evidence suggest an involvement of these enzymes and their products in skin barrier function in all normal subjects. The natural occurrence of the specific hepoxilin products, and their biological role, whether structural or signaling, remain to be defined.
近期,关于脂氧合酶(LOX)酶活性的遗传学和生物化学证据相互印证,这表明在导致表皮外层形成不透水屏障的途径中,存在肝氧素衍生物(脂肪酸环氧醇)的生成。在一种罕见的先天性鱼鳞病中,12R-脂氧合酶和表皮脂氧合酶3发生了突变,并且在体外,这两种酶共同作用可将花生四烯酸转化为特定的肝氧素。综合这些证据表明,在所有正常受试者中,这些酶及其产物参与了皮肤屏障功能。特定肝氧素产物的天然存在及其生物学作用,无论是结构方面还是信号传导方面,仍有待确定。